Work

Genome-scale CRISPR-Cas9 knockout studies to characterize the mechanisms of myeloma cell treatment resistance.

Year: 2015

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2015.07.172

Authors: Y. Hu, M. Sheffer, G.M. Matthews, P. Hengeveld, O. Shalem, F. Zhang, E. Dhimolea, S. Sarkar, M. Bariteau, B. Aftab, R. Groen, C.S. Mitsiades

Institutions: Harvard University, Dana-Farber Cancer Institute, Broad Institute, University of California, San Francisco

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2197777720

FWCI:

Cites:

Cited by: 1

Related to: 10